Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles. 1984

T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada

Effects of bepridil, a new antianginal and potential antiarrhythmic agent, on transmembrane action potentials of ventricular muscles were examined in isolated right ventricular papillary muscles of guinea-pig. Bepridil at concentrations above 5 X 10(-6)M caused a dose-dependent decrease in both the maximum upstroke velocity (Vmax) and the action potential duration from the upstroke to 30% repolarization ( APD30 ). On the other hand, the resting potential (RP), the amplitude of action potential (AMP), and the action potential duration from the upstroke to 90% repolarization ( APD90 ) were not affected even at the highest concentration applied (10(-5)M). The curves relating membrane potential and Vmax were shifted by bepridil at 5 X 10(-6)M along the voltage axis in the direction of more negative potentials. The recovery kinetics of Vmax assessed by premature stimuli were definitely slowed by bepridil at above 10(-6)M. This effect was more pronounced with higher [K+]o (10 mM) than normal [K+]o (5 mM). Bepridil at 5 X 10(-6)M caused a rate-dependent decrease of Vmax (use-dependent block) with rapid onset and offset, as did lidocaine. Slow responses, which had been induced by isoprenaline (5 X 10(-6)M) in K+-depolarized preparations, were suppressed significantly by additional application of bepridil at 10(-5)M. These findings suggest that bepridil has electrophysiological characteristics similar to those both of Class Ib and Class IV antiarrhythmic drugs.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010210 Papillary Muscles Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae. Muscle, Papillary,Muscles, Papillary,Papillary Muscle
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D015764 Bepridil A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. 1978-CERM,Bedapin,Bepadin,Bepridil Monohydrochloride,Bepridil Monohydrochloride, Monohydrate,Bepridil Monohydrochloride, alpha-Isomer,Bepridil, (+)-Isomer,Bepridil, (+-)-Isomer,Bepridil, (-)-Isomer,Bepridil, alpha-Isomer,CERM-1978,Cordium,Unicordium,Vascor,1978 CERM,1978CERM,Bepridil Monohydrochloride, alpha Isomer,Bepridil, alpha Isomer,CERM 1978,CERM1978,Monohydrochloride, Bepridil,Monohydrochloride, alpha-Isomer Bepridil

Related Publications

T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
August 1985, The Journal of pharmacology and experimental therapeutics,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
October 1992, British journal of pharmacology,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
January 1990, General pharmacology,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
May 2003, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
December 2004, Sheng li xue bao : [Acta physiologica Sinica],
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
October 2003, Sheng li xue bao : [Acta physiologica Sinica],
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
May 1996, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
April 1979, European journal of pharmacology,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
January 2013, Biological & pharmaceutical bulletin,
T Anno, and T Furuta, and M Itho, and I Kodama, and J Toyama, and K Yamada
October 1994, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!